top of page
Browse by category
Search
FDA grants Breakthrough Device Designation for Fractyl’s Revita in weight maintenance for people with obesity who discontinue GLP-1s
The FDA has granted Breakthrough Device Designation (BDD) for Fractyl Health’s Revita System for use in the maintenance of weight loss...
Phenomix launches personalised obesity care genetic testing available to women in with Hello Alpha partnership
Phenomix Sciences has entered a partnership with Hello Alpha, a virtual primary care platform, to enable women to take control of their...
ReShape Lifesciences sells obesity devices to Biorad Medisys
ReShape has entered into an asset purchase agreement with Biorad Medisys, which is party to a previously disclosed exclusive license...
iHerb launches new GLP-1 support products designed to combat common side effects from rapid weight loss
iHerb has launched three new supplements specifically designed to support individuals using semaglutide (GLP-1 agonists) by addressing...
WHO issues warning on falsified medicines as Lilly warns patients about counterfeit and compounded medicines
The World Health Organization (WHO) has issued a medical product alert on falsified semaglutides, the type of medicines that are used for...
Unjury Protein launches Protect & Restore Advanced Protein+ to reduce side effects of GLP-1 RAs
Unjury Protein has launched its Protect & Restore Advanced Protein+ - the first clinically supported medical food and co-therapy for...
Aphaia Pharma completes enrolment of phase 2 trial in individuals with obesity
Aphaia Pharma, a clinical-stage company harnessing precision-targeted drug formulations to restore endogenous endocrine balance for the...
Scottish Medicines Consortium accepts tirzepatide (Mounjaro) for obesity in eligible adults
The Scottish Medicines Consortium (SMC) has accepted Eli Lilly and Company’s tirzepatide (Mounjaro) for restricted use within NHS...
Karl Storz to acquire Asensus Surgical
Asensus Surgical has entered into a definitive merger agreement with Karl Storz Endoscopy-America, a wholly owned direct subsidiary of...
Medtronic launches new AI analysis for laparoscopic and robotic-assisted procedures
Medtronic has announced the launch of new AI algorithms for post-operative analysis, providing AI surgical insights across laparoscopic...
Browse by tag
bottom of page